Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation TCT 2018

Managing a Busy LAA Closure Program: Patient Selection, Education, Consent, Screening, and Periprocedural Care

Presenter: James B. Hermiller Jr, David Hildick-Smith, George S. Hanzel

September 24, 2018

Presentation TCT 2018

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Presenter: James B. Hermiller Jr, David Hildick-Smith, Martin W. Bergmann

September 24, 2018

Presentation TCT 2018

Essential of Pre-procedural Imaging and Intra-procedural Guidance

Presenter: James B. Hermiller Jr, David Hildick-Smith, Jacqueline Saw

September 24, 2018

Presentation TCT 2018

Shared Decision-making in NVAF: The Patients Perspective

Presenter: James B. Hermiller Jr, David Hildick-Smith, Megan Coylewright

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr.

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Presenter: James B. Hermiller Jr, David Hildick-Smith, Freek W.A. Verheugt

September 24, 2018

Presentation TCT 2018

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

Presenter: James B. Hermiller Jr, David Hildick-Smith, David E. Thaler

September 24, 2018

Presentation TCT 2018

EBC Perspectives on LM Stenting Technique and the EBC Main Trial

Presenter: Antonio Colombo, Leif Thuesen, David Hildick-Smith

September 23, 2018

Presentation TCT 2018

Jailing and Removing Side Branch Wires: Technique and Safety

Presenter: Antonio Colombo, Jean Fajadet, David Hildick-Smith

September 23, 2018

Presentation TCT 2018

More Than a Decade of Insights From the European Bifurcation Club (LM and Non-LM)

Presenter: Bernard R. Chevalier, David Hildick-Smith, Jens Flensted Lassen

September 23, 2018

Presentation TCT 2018

Implications of Varied Stent Designs for Bifurcation Stenting (LM and Non-LM)

Presenter: Bernard R. Chevalier, David Hildick-Smith, Nicolas Foin

September 23, 2018

Presentation TCT 2018

New Bench Insights Into Optimal Bifurcation Stenting (LM and Non-LM)

Presenter: Bernard R. Chevalier, David Hildick-Smith, John A. Ormiston

September 23, 2018

Presentation TCT 2018

Bifurcation and Left Main Stenting Introduction: What You May Have Missed in the Last Year

Presenter: Bernard R. Chevalier, David Hildick-Smith, Bimmer E. Claessen

September 23, 2018

Presentation TCT 2018

Case# 2: Should This PFO Be Closed in a Patient With a TIA?

Presenter: Michael J. Mullen, David E. Thaler, Joseph P. Carrozza Jr, Ted Feldman, Craig E Fleishman, David Hildick-Smith, Jacqueline Saw, Jochen Wöhrle

September 22, 2018

Presentation TCT 2018

TCT-44: Comparative Effectiveness and Safety of Five Leading New-Generation TAVI Devices: 12-Month Results from The RISPEVA Study

Presenter: David Hildick-Smith, Martin B. Leon, Giuseppe Biondi-Zoccai

September 21, 2018

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: David Hildick-Smith, Martin B. Leon, Andrejs Erglis

September 21, 2018

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: David Hildick-Smith, Martin B. Leon, Andrejs Erglis

September 21, 2018

Presentation TCT 2018

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

Presenter: David Hildick-Smith, Martin B. Leon, Hendrik Treede

September 21, 2018

Presentation TCT 2018

TCT-41: Acute and Six-month Outcomes of a Novel Self-Expanding Transcatheter Heart Valve

Presenter: David Hildick-Smith, Martin B. Leon, Ulrich Schäfer

September 21, 2018

Presentation CIT 2018

Structural Heart Disease: What’s new in 2018?

Presenter: David Hildick-Smith

March 23, 2018

Advertisement

Managing a Busy LAA Closure Program: Patient Selection, Education, Consent, Screening, and Periprocedural Care

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Essential of Pre-procedural Imaging and Intra-procedural Guidance

Shared Decision-making in NVAF: The Patients Perspective

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

EBC Perspectives on LM Stenting Technique and the EBC Main Trial

Jailing and Removing Side Branch Wires: Technique and Safety

More Than a Decade of Insights From the European Bifurcation Club (LM and Non-LM)

Implications of Varied Stent Designs for Bifurcation Stenting (LM and Non-LM)

New Bench Insights Into Optimal Bifurcation Stenting (LM and Non-LM)

Bifurcation and Left Main Stenting Introduction: What You May Have Missed in the Last Year

Case# 2: Should This PFO Be Closed in a Patient With a TIA?

TCT-44: Comparative Effectiveness and Safety of Five Leading New-Generation TAVI Devices: 12-Month Results from The RISPEVA Study

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

TCT-42: An Early Feasibility Study to Assess Safety and Effectiveness of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Stenosis (AS)

TCT-41: Acute and Six-month Outcomes of a Novel Self-Expanding Transcatheter Heart Valve

Structural Heart Disease: What’s new in 2018?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content